Boston Sci's Innova OK'd By FDA To Treat Peripheral Artery Disease
This article was originally published in The Gray Sheet
Executive Summary
The vascular self-expanding stent system has been approved as an advanced treatment for patients with narrowing or blockages in their superficial femoral artery or proximal popliteal artery, which can lead to peripheral artery disease – a condition that affects 8 million Americans.
You may also be interested in...
Corrosion Testing For Nickel Stents Front And Center In FDA Final Update
The agency says it has taken into account feedback from industry during a 2013 workshop on the risks of nickel stents, and has reduced its requirements for standard corrosion testing while also outlining steps on when to adopt different corrosion testing methods.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.